Forecast & RatingOnly 1 analyst currently covers Galmed Pharma (GLMD.US), with a price target of $12.00 and a rating of "Hold". The sample is very small, so treat this as a reference only. Data as of Aug 18, 2026; this does not constitute investment advice.
Jun 9, 2026Price forecast
$12.002146.77%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met4.5%
Stock price$0.55
Avg. target$12.0
High target$12
Low target$12
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.